by McKesson Ventures | May 1, 2024 | Media Coverage
On May 1, 2024, growth investor and executive insights company GrowthCap named McKesson Ventures’ Managing Director Dave Schulte as one of its Top 25 Healthcare Investors of 2024. The list, published annually and founded in 2021, seeks to acknowledge individuals who...
by McKesson Ventures | Mar 11, 2024 | Media Coverage
McKesson Ventures Vice President and Partner Carrie (Hurwitz) Williams was named as one of Global Corporate Venturing (GCV)’s top “Emerging Leaders for 2024”! Announced on Monday, March 11th, Williams was praised by GCV for her experience with “the business...
by McKesson Ventures | Jun 29, 2023 | Media Coverage, Portfolio News
Last year, McKesson Ventures joined a group of funders including Merck, Microsoft, the Global Health Innovation Fund, Northpond Ventures, and the New Jersey Institute of Technology to bring to life a “founder-friendly” startup accelerator for companies in the...
by McKesson Ventures | Jun 9, 2023 | Industry News, Media Coverage
McKesson Ventures Vice President & Partner Carrie Williams spoke at the Digital Healthcare Innovation Summit, East Coast, which took place June 6 and 7, 2023, in Boston. Williams participated in a panel discussion titled “Beyond the Clinic: Digital &...
by McKesson Ventures | Jun 6, 2023 | Media Coverage, Press Releases
McKesson Ventures has participated in a $17.5 million Series A round for RxLightning, a platform for streamlining access and affordability for specialty medications. This brings the total the company has raised since its inception to $20.5 million. With RxLightning,...
by McKesson Ventures | Jun 29, 2022 | Media Coverage, Press Releases
Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct...
